BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 2580011)

  • 1. Susceptibility of cytotoxic T lymphocyte (CTL) clones to inhibition by anti-T3 and anti-T4 (but not anti-LFA-1) monoclonal antibodies varies with the "avidity" of CTL-target interaction.
    Shaw S; Goldstein G; Springer TA; Biddison WE
    J Immunol; 1985 May; 134(5):3019-26. PubMed ID: 2580011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a regulatory role of the T8 (CD8) antigen in antigen-specific and anti-T3-(CD3)-induced lytic activity of allospecific cytotoxic T lymphocyte clones.
    Van Seventer GA; Van Lier RA; Spits H; Ivanyi P; Melief CJ
    Eur J Immunol; 1986 Nov; 16(11):1363-71. PubMed ID: 2430810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-T3 antibody both activates and inhibits the cytotoxic activity of human T cell clones.
    Hoffman RW; Quinones RR; Shaw S
    Behring Inst Mitt; 1985 Aug; (77):30-8. PubMed ID: 3936472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One allogeneic cytolytic T lymphocyte clone distinguishes three different HLA-B27 subtypes: identification of amino acid residues influencing the specificity and avidity of recognition.
    Aparicio P; Vega MA; López de Castro JA
    J Immunol; 1985 Nov; 135(5):3074-81. PubMed ID: 2413111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T3 monoclonal antibody activation of nonspecific cytolysis: a mechanism of CTL inhibition.
    Mentzer SJ; Barbosa JA; Burakoff SJ
    J Immunol; 1985 Jul; 135(1):34-8. PubMed ID: 2582036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells.
    Schmidt RE; Bartley G; Levine H; Schlossman SF; Ritz J
    J Immunol; 1985 Aug; 135(2):1020-5. PubMed ID: 3924996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of nonspecific cytotoxicity by monoclonal anti-T3 antibodies.
    Leeuwenberg JF; Spits H; Tax WJ; Capel PJ
    J Immunol; 1985 Jun; 134(6):3770-5. PubMed ID: 2580895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avidity dictates the lytic capacity of human cytolytic T lymphocyte clones with similar fine specificity against murine cells expressing HLA-B27 antigen.
    Calvo V; Rojo S; Aparicio P; Galocha B; López de Castro JA
    J Immunol; 1988 Dec; 141(11):3798-803. PubMed ID: 2460549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing.
    Gromkowski SH; Heagy W; Martz E
    J Immunol; 1985 Jan; 134(1):70-7. PubMed ID: 3880579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LFA-1, LFA-2, and LFA-3 antigens are involved in CTL-target conjugation.
    Krensky AM; Robbins E; Springer TA; Burakoff SJ
    J Immunol; 1984 May; 132(5):2180-2. PubMed ID: 6201533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of accessory molecules in signal transduction of cytolytic T lymphocyte by anti-T cell receptor and anti-Ly-6.2C monoclonal antibodies.
    Leo O; Foo M; Henkart PA; Perez P; Shinohara N; Segal DM; Bluestone JA
    J Immunol; 1987 Dec; 139(11):3556-63. PubMed ID: 3316387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the T cell receptor, CD8, and LFA-1 in different stages of the cytolytic reaction mediated by alloreactive T lymphocyte clones.
    Blanchard D; van Els C; Borst J; Carrel S; Boylston A; de Vries JE; Spits H
    J Immunol; 1987 Apr; 138(8):2417-21. PubMed ID: 3104466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytolytic T lymphocyte interactions with vascular endothelium and fibroblasts: role of effector and target cell molecules.
    Collins T; Krensky AM; Clayberger C; Fiers W; Gimbrone MA; Burakoff SJ; Pober JS
    J Immunol; 1984 Oct; 133(4):1878-84. PubMed ID: 6432903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cytotoxic T cell lysis by anti-CD8 monoclonal antibodies: studies with CD3-targeted cytolysis of nominal antigen-negative targets.
    Quinones RR; Segal DM; Henkart P; Perez P; Gress RE
    J Immunol; 1989 Apr; 142(7):2200-6. PubMed ID: 2466891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both LFA-1-positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activation.
    Van de Wiel-van Kemenade E; Te Velde AA; De Boer AJ; Weening RS; Fischer A; Borst J; Melief CJ; Figdor CG
    Eur J Immunol; 1992 Jun; 22(6):1467-75. PubMed ID: 1376259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
    Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
    J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
    Galocha B; López D; López de Castro JA
    J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of anti-CD8-resistant cytolytic T lymphocytes induced by multivalent cross-linking of CD8 on precursor cells.
    McCarthy SA; Kaldjian E; Singer A
    J Immunol; 1989 Oct; 143(7):2112-9. PubMed ID: 2528588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.